Development and application of an uncapped mRNA platform
Background A novel uncapped mRNA platform was developed.Methods Five lipid nanoparticle (LNP)-encapsulated mRNA constructs were made to evaluate several aspects of our platform, including transfection efficiency and durability in vitro and in vivo and the activation of humoral and cellular immunity...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Taylor & Francis Group
2025-12-01
|
| Ráidu: | Annals of Medicine |
| Fáttát: | |
| Liŋkkat: | https://www.tandfonline.com/doi/10.1080/07853890.2024.2437046 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
